Publication | Open Access
Inhibition of MDM2 Re-Sensitizes Rapamycin Resistant Renal Cancer Cells via the Activation of p53
15
Citations
15
References
2016
Year
Our study reports a novel mechanism for rapamycin resistance in human renal cancer and provides a new perspective for the development of anti-cancer drugs.
| Year | Citations | |
|---|---|---|
Page 1
Page 1